| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |